Advanced Papillary Renal Cell Carcinoma
1 clinical trials · Condition
◉ Watch Advanced Papillary Renal Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer (NCT05122546) | City of Hope Medical Center | 2021-11-01 |
Track Advanced Papillary Renal Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.